Comparisons of clinical findings and serological data in the diagnosis of canine leishmaniosis

Basit Öğe Kaydı
dc.contributor.authorÖzensoy Töz S.
dc.contributor.authorÖzbel Y.
dc.contributor.authorErtabaklar H.
dc.contributor.authorYildizli N.
dc.contributor.authorKorkmaz M.
dc.contributor.authorAlkan M.Z.
dc.date.accessioned2019-10-27T00:10:42Z
dc.date.available2019-10-27T00:10:42Z
dc.date.issued2005
dc.departmentEge Üniversitesien_US
dc.description.abstractThis study aimed to evaluate clinical signs related with canine leishmaniosis (CanL) and to determine their relation with serological results in the differential diagnosis of this disease in dog populations. A total of 253 dogs from houses and a dog shelter in Kuşadasi, an endemic region for leishmaniosis, were investigated for clinical signs related to CanL. Sera collected from the study group were examined by indirect fluorescence antibody (IFA), whole ELISA and rK39 ELISA tests for the serological diagnosis. Popliteal lymph node aspiration materials were examined for the parasitological diagnosis. Clinical signs were separated into two groups as cutaneous and visceral signs and no clinical signs were observed in 51.7% (131/253) of the dogs, while 48.3% (122/253) of the dogs had at least one sign. A total of 42 dogs [29 (23.7%) in the symptomatic and 13 (9.9%) in the asymptomatic group] were diagnosed as CanL serologically and/or parasitologically. Two strains were isolated and identified as Leishmania infantum MON-1. There was no correlation between IFAT titers and the number of the clinical signs (P > 0.05; R square = 0.002). Weight loss was found to be the most common sign of CanL while epistaxis was the least common but specific sign. The seropositivity ratio of CanL is 16.6% (42/253) among dogs in the region and clinical signs were found to be helpful for suspecting CanL but at least one serological and/or parasitological method should be performed for the accurate and differential diagnosis in the dogs. Our findings also showed that the one-third of the dogs in an endemic area for CanL could be asymptomatic. © TÜBİTAK.en_US
dc.identifier.endpage273en_US
dc.identifier.issn1300-0128
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage269en_US
dc.identifier.urihttps://hdl.handle.net/11454/22029
dc.identifier.volume29en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Veterinary and Animal Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanine leishmaniosisen_US
dc.subjectClinical signsen_US
dc.subjectDiagnosisen_US
dc.subjectTurkeyen_US
dc.titleComparisons of clinical findings and serological data in the diagnosis of canine leishmaniosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu